Since TGF-β1 is one of the key regulators of HSC activation [1], it is also possible that casticin inhibits autocrine/paracrine signaling in activated HSCs, thereby facilitating resolution of CCl4- or BDL-induced hepatic fibrosis in vivo. Here, TGFB1 is linked to Hepatic fibrosis.